GlassScriptPhysician profile
Samuel A Carrell
NPI 1124422571
$2,544.77
in general payments reported to CMS, 2019-2025
11 companies · $985 in 2025
The $985 reported for 2025 was more than what 95% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $115 · 2021: $142 · 2022: $185 · 2023: $120 · 2024: $833 · 2025: $985.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,691 · Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,690.70 |
| Food and Beverage | $247.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $1,818.61 | 2024-2025 | 3m Filtek, Clarity Advanced, 3m |
| Align Technology, INC. | $306.91 | 2019-2022 | |
| Pulpdent Corporation | $81.06 | 2023 | |
| Straumann USA LLC | $75.00 | 2019 | |
| Dentsply Sirona INC | $68.43 | 2021-2022 | |
| Biolase, INC. | $60.00 | 2019 | |
| Kerr Corporation | $43.33 | 2022 | |
| 3m Company | $32.70 | 2020-2023 | 3m Relyx, 3m Espe Filtek Supreme Ultra Universal Restorative, Scotchbond Universal Plus |
| Philips North America LLC | $25.96 | 2020-2022 | |
| Nobel Biocare USA | $21.96 | 2023 | Nobelactive |
| Voco America INC. | $10.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Carrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.